Zhou Zhu M.D., Ph.D.

Associate Professor of Pediatrics (Immunology) and of Medicine (Immunology)

Research Interests

Our studies are on glycoligand receptors, siglecs, that are expressed on the immune cells such as eosinophils (Siglec-8) and neutrophils (Siglec-9) in specific pulmonary diseases. The unique expression patterns of these siglecs, the specific binding to glycoligands, and the consequent cellular responses, including apoptosis, are being explored as potential targets and pathways for the development of effective therapeutic approaches for pulmonary diseases.

Current Projects

Glycobiology of inflammatory lung diseases

Siglec-8 in eosinophil inflammation and asthma

Siglec-9 in neutrophil inflammation and COPD

SHP-1 regulation of allergic and inflammatory diseases

Role of SHIP-1 in anaphylaxis and asthma


Research Summary

Pulmonary inflammation is an important immune response that underlies many diseases, including asthma and COPD. Cytokines, chemokines, and other factors play important roles in initiation, regulation, and resolution of inflammation in the lung. Our laboratory is interested in understanding the molecular mechanisms and specific pathways that regulate inflammation. Our studies involve patient samples including tissues and cells and we utilize animal models of allergen induced, cytokine induced, and spontaneous inflammatory responses in the lung. These include allergen sensitization and challenge models, transgenic models in which specific cytokines or factors are targeted to the lung, and natural mutant models. Using these models and techniques we will be able to identify novel molecules and pathways that mediate or regulate pulmonary inflammation. These studies will help us in exploring new therapeutic strategies for the treatment of inflammatory pulmonary diseases.

A more recent focus of our studies is on glycoligand receptors, siglecs, that are expressed on the immune cells such as eosinophils (Siglec-8) and neutrophils (Siglec-9) in specific pulmonary diseases. The unique expression patterns of these siglecs, the specific binding to glycoligands, and the consequent cellular responses, including apoptosis, are being explored as potential targets and pathways for the development of effective therapeutic approaches for pulmonary diseases.


Selected Publications

  • Wang, Y., Z. Zhu, T. D. Church, N. L. Lugogo, D. Francisco, J. L. Ingram, M. Huggins, D. Beaver, J. R. Wright, and M. Kraft. 2012. Role of SHP-1 in the regulation of Mycoplasma pneumoniae-induced inflammation in asthmatic airway epithelial cells. J Immunol 188:3371-3381.
  • Aloulou, M., S. B. Mkaddem, M. Biarnes-Pelicot, T. Boussetta, H. Souchet, E. Rossato, M. Benhamou, B. Crestani, Z. Zhu, U. Blank, P. Launay, and R. C. Monteiro. 2012. IgG1 and IVIg induce inhibitory ITAM signaling through FcgammaRIII controlling inflammatory responses. Blood 119:3084-3096.
  • Cho, S. H., S. Y. Oh, Z. Zhu, J. Lee, and A. P. Lane. 2012. Spontaneous eosinophilic nasal inflammation in a genetically-mutant mouse: comparative study with an allergic inflammation model. PLoS ONE 7(4):e35114.
  • Yu, J., M. H. Oh, J. U. Park, A. C. Myers, C. Dong, Z. Zhu, and T. Zheng. 2012. Epicutaneous exposure to staphylococcal superantigen enterotoxin B enhances allergic lung inflammation via an IL-17A dependent mechanism. PLoS One 7(7):e39032.
  • Zhou, L., S. Y. Oh, Y. Zhou, B. Yuan, F. Wu, M. H. Oh, Y. Wang, C. Takemoto, N. Van Rooijen, T. Zheng, and Z. Zhu. 2013. SHP-1 Regulation of Mast Cell Function in Allergic Inflammation and Anaphylaxis. PLoS One 8:e55763.
  • Kim, Y. S., E. J. Choi, W. H. Lee, S. J. Choi, T. Y. Roh, J. Park, Y. K. Jee, Z. Zhu, Y. Y. Koh, Y. S. Gho, and Y. K. Kim. 2013. Extracellular vesicles, especially derived from Gram-negative bacteria, in indoor dust induce neutrophilic pulmonary inflammation associated with both Th1 and Th17 cell responses. Clin Exp Allergy 43:443-454.
  • Kiwamoto, T., M. E. Brummet, F. Wu, M. G. Motari, D. F. Smith, R. L. Schnaar, Z. Zhu, and B. S. Bochner. 2013. Mice deficient in the St3gal3 gene product alpha2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation. J Allergy Clin Immunol (E-Published July 2, 2013).
  • Oh, M. H., S. Y. Oh, J. N. Lu, H. F. Lou, A. C. Myers, Z. Zhu, and T. Zheng. 2013. TRPA1-Dependent Pruritus in IL-13-Induced Chronic Atopic Dermatitis. J Immunol (Accepted).

Edit Profile